Le brevet: une stratégie pour l'entreprise : CIC-IT = The patent: Strategy for companiesRIPART, A.IRBM. 2010, Vol 31, Num 1, pp 22-25, issn 1959-0318, 4 p.Article

Dispensing with Conscience : A Legal and Ethical AssessmentWERNOW, Jerome R; GRANT, Donald G.The Annals of pharmacotherapy. 2008, Vol 42, Num 11, pp 1669-1678, issn 1060-0280, 10 p.Article

Enquête de satisfaction d'un pôle médico-technique : bilan et perspectives d'un service de pharmacie = Healthcare practitionner satisfaction assessment regarding pharmaceutical service in anfrench hospital departmentDEMANGE, Claude; NOËL, Simone; VINOT, Nathalie et al.Le Pharmacien hospitalier. 2008, Vol 43, Num 175, pp 227-232, issn 0768-9179, 6 p.Article

Caracterización de la indicación farmacéutica en farmacias comunitarias de Sevilla capital (España). Estudio piloto = Characterization of counseling for Non-Prescription Drugs at communities pharmacies of Seville (Spain). Pilot StudyFERRER-LOPEZ, I; MACHUCA, M; BAENA, M. I et al.Ars Pharmaceutica. 2007, Vol 48, Num 4, pp 371-385, issn 0004-2927, 15 p.Article

Les classes thérapeutiques risquent-elles de tuer l'innovation pharmaceutique ?SOULAS, C.Journal d'économie médicale. 2006, Vol 24, Num 6, pp 307-321, issn 0294-0736, 15 p.Article

Analogpräparate: Marktstrategien der Arzneimittelhersteller wie der Arzneimitteleinkäufer am Beispiel nichtionischer (monomerer) Röntgenkontrastmittel = Me-too pharmaceuticals: Marketing-strategies of drugproducers and drug purchasers. Example: Non-ionic contrast mediaWILD, C; S.PUIG.Das Gesundheitswesen (Stuttgart. Thieme). 2004, Vol 66, Num 11, pp 716-722, issn 0941-3790, 7 p.Article

Initiatives to control drug costs associated with an independent physician associationABOURJAILY, Paul; KROSS, Joan; GOUVEIA, William A et al.American journal of health-system pharmacy. 2003, Vol 60, Num 3, pp 269-272, issn 1079-2082, 4 p.Article

European healthcare policies for controlling drug expenditureESS, Silvia M; SCHNEEWEISS, Sebastian; SZUCS, Thomas D et al.PharmacoEconomics (Auckland). 2003, Vol 21, Num 2, pp 89-103, issn 1170-7690, 15 p.Article

Pharmaceutical manufacturer assistance programsCHISHOLM, Marie A; DIPIRO, Joseph T.Archives of internal medicine (1960). 2002, Vol 162, Num 7, pp 780-784, issn 0003-9926Article

Pharmaceutical sales representatives and the doctor/patient relationshipWALL, L. Lewis; BROWN, Douglas.Obstetrics and gynecology (New York. 1953). 2002, Vol 100, Num 3, pp 594-599, issn 0029-7844Article

The product label: How pharmacokinetics and pharmacodynamics reach the prescriberMARROUM, Patrick J; GOBBURU, Jogarao.Clinical pharmacokinetics. 2002, Vol 41, Num 3, pp 161-169, issn 0312-5963Article

Accountability of the pharmaceutical industryDUKES, M. N.Lancet (British edition). 2002, Vol 360, Num 9346, pp 1682-1684, issn 0140-6736, 3 p.Article

Gastroenterology and the pharmaceutical industryRAKATANSKY, H.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 11, pp 1859-1866, issn 0269-2813, 8 p.Article

Understanding and preparing for clinical drug trial auditsSIDEN, Rivka; TANKANOW, Roberta M; TAMER, Helen R et al.American journal of health-system pharmacy. 2002, Vol 59, Num 23, pp 2301-2306, issn 1079-2082, 2 p.Article

Place des Visiteurs médicaux dans l'information pharmaceutique des Médecins généralistes de la région sanitaire de Sousse (Tunisie) = The role of medical visitors in the pharmaceutical information of general practitioners in Sousse (Tunisia)BEN ABDELAZIZ, A; RAHMANI, S; HARRABI, I et al.Archives of public health. 2002, Vol 60, Num 5, pp 295-308, issn 0778-7367, 14 p.Article

Pharmaceutical price controls and patient welfareCALFEE, John E.Annals of internal medicine. 2001, Vol 134, Num 11, pp 1060-1064, issn 0003-4819Article

Projecting future drug expenditures-2001MEHL, Bernard; SANTELL, John.American journal of health-system pharmacy. 2001, Vol 58, Num 2, pp 125-133, issn 1079-2082Article

Public-private health partnerships : a strategy for WHOBUSE, Kent; WAXMAN, Amalia.Bulletin of the World Health Organization. 2001, Vol 79, Num 8, pp 748-754, issn 0042-9686Article

Real world pharmacy : assessing the quality of private pharmacy practice in the Lao People's Democratic RepublicSTENSON, Bo; SYHAKHANG, Lamphone; ERIKSSON, Bo et al.Social science & medicine (1982). 2001, Vol 52, Num 3, pp 393-404, issn 0277-9536Article

Modulating the profit motive to meet needs of the less-developed world. CommentarySCHIEPPATI, Arrigo; REMUZZI, Giuseppe; GARATTINI, Silvio et al.Lancet (British edition). 2001, Vol 358, Num 9293, issn 0140-6736, 1570,1638-1641 [5 p.]Article

Pharmaceutical industry-sponsored meetings : good value or just a free meal?CARNEY, S. L; NAIR, K. R; SALES, M. A et al.Internal medicine journal (Print). 2001, Vol 31, Num 8, pp 488-491, issn 1444-0903Conference Paper

Trading risks for markets : the international harmonisation of pharmaceuticals regulationABRAHAM, John; REED, Tim.Health, risk & society (Print). 2001, Vol 3, Num 1, pp 113-128, issn 1369-8575Article

A role for public-private partnerships in controlling neglected diseases? DiscussionRIDLEY, Robert G; LOB-LEVYT, Julian; SACHS, Jeffrey et al.Bulletin of the World Health Organization. 2001, Vol 79, Num 8, pp 771-777, issn 0042-9686Article

Drug studies in developing countriesOLLIARO, Piero L; VIJAYAN, Ramani; INBASEGARAN, K et al.Bulletin of the World Health Organization. 2001, Vol 79, Num 9, pp 894-895, issn 0042-9686Article

Separating continuing medical education from pharmaceutical marketingRELMAN, Arnold S.JAMA, the journal of the American Medical Association. 2001, Vol 285, Num 15, pp 2009-2012, issn 0098-7484Article